ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

CRVS Corvus Pharmaceuticals Inc

1,70
0,09 (5,59%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:00:04
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Corvus Pharmaceuticals Inc CRVS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,09 5,59% 1,70 22:00:04
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,76 1,68 1,78 1,70 1,61
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202422:02GLOBECorvus Pharmaceuticals to Provide Business Update and First..
02.5.202414:30GLOBECorvus Pharmaceuticals Announces Pricing of $30.6 Million..
09.4.202422:01GLOBECorvus Pharmaceuticals Announces Initiation of..
19.3.202421:02GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
19.3.202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
13.3.202421:02GLOBECorvus Pharmaceuticals to Provide Business Update and Fourth..
01.3.202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202414:30GLOBECorvus Pharmaceuticals Presents Soquelitinib Preclinical..
08.2.202422:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
08.2.202422:05GLOBECorvus Pharmaceuticals Announces Orphan Drug Designation..
06.2.202422:05GLOBECorvus Pharmaceuticals Appoints Jeffrey Arcara as Chief..
23.1.202423:00EDGAR2Form 8-K - Current report
23.1.202423:00GLOBECorvus Pharmaceuticals Announces the Passing of Board Member..
09.12.202318:00GLOBECorvus Pharmaceuticals Presents New Interim Soquelitinib..
08.12.202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.12.202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.11.202322:03EDGAR2Form 8-K - Current report
07.11.202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
02.11.202314:15GLOBECorvus Pharmaceuticals to Present New Interim Soquelitinib..
02.11.202300:31GLOBECorvus Pharmaceuticals Announces Publication of Preclinical..
31.10.202321:02GLOBECorvus Pharmaceuticals to Provide Business Update and Report..
06.9.202322:05GLOBECorvus Pharmaceuticals Confirms Planned Initiation of..
08.8.202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:01EDGAR2Form 8-K - Current report
08.8.202322:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
01.8.202314:30GLOBECorvus Pharmaceuticals to Provide Business Update and Report..
06.7.202318:59GLOBECorvus Pharmaceuticals Announces Publication of Preclinical..
29.6.202313:00GLOBECorvus Pharmaceuticals Presents New Ciforadenant Preclinical..
15.6.202313:00GLOBECorvus Pharmaceuticals Presents New CPI-818 Interim Data at..
31.5.202314:30GLOBECorvus Pharmaceuticals to Present at the Jefferies..
17.5.202315:00GLOBECorvus Pharmaceuticals to Present New CPI-818 Data at the..
08.5.202322:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock